CITIC Capital has agreed to buy Trilogy International (TIL), a producer of skincare products and fragrances listed in New Zealand and Australia, for NZ$250 million ($175 million) via a scheme of arrangement.
The China-focused GP will buy all outstanding shares in the company for NZ$2.90 apiece, a 27.8% premium to the December 14 closing price. The enterprise valuation equates to 13.6x EBITDA for the 12 months...
SeaLink Capital Partners has led a INR2 billion ($29 million) investment in Indian maternal and pediatric hospital chain Surya Children’s Medicare, providing an exit for OrbiMed Advisors.
Japan's governance reforms have given activist investors more leverage over underperforming companies. PE firms are well positioned to offer solutions to these targets in the form of carve-outs, privatizations, or partnerships
Chinese B2B pharmaceutical trading and education platform Yaoshibang has received RMB420 million ($65 million) in Series C funding across two tranches.
A group of VCs including China Growth Capital have agreed to invest $16 million in Ono, a China-based company that claims to be the creator of the first decentralized social network.